first month glp-1 treatment expectations Most patients who discontinue in the few months do so for preventable reasons. Not because the therapy “failed.” But because: -dosing moved too quickly -expectations weren't managed -nutrition wasn't Clinical Recommendations to Manage Gastrointestinal
Description
How do they work

Moreover, it remains to be shown that GIPR agonism can improve insulin secretion in type 2 diabetic patients who have been noted in previous studies to be unresponsive to GIP

Free retatrutide dosage chart with the full 2mg to 12mg titration schedule

To further note, in the field of weight-loss treatment, significant work is underway in parallel, on GIP agonist, amylin agonist, glucagon agonist, PYY agonist, either separately or in combination especially with GLP-1 agonist.

These medications also delay gastric emptying through neural mechanisms, increasing the risk for perioperative aspiration during anaesthesia and sedation

Stabilizes blood sugar fewer spikes & crashes
